NEW YORK / Jul 15, 2024 / Business Wire / DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary has launched emergency medical and 911 services in Dover, Delaware.
On July 1, 2024, Ambulnz began providing basic life support (BLS) ambulances 24 hours a day, seven days a week, operating out of three stations in the Dover Fire District. The services are supported by a local management team and over 50 EMS field professionals. Ambulnz will now provide 911 services to the roughly 38,000 residents of Dover over the course of a three-year contract, which was awarded through a competitive bidding process.
This launch of 911 services represents an expansion of DocGo’s ongoing work in Dover, where the company has supported the Bayhealth system of hospitals since January 2022.
“We appreciate the trust that the City of Dover is placing in us to provide its residents with 911 and emergency medical services,” said Tyler Selak, Senior Director of Operations, DocGo. “Our trained medical professionals are local EMTs and paramedics with prior experience working in 911 systems. We will leverage our Dover EMS Division Ambulnz vehicles for efficient and effective emergency response, as well as support in special event standby services.”
Ambulnz has worked to ensure a seamless transition from the previous 911 service provider and offered employment to staff in good standing who wish to continue working in the area.
“Ambulnz’s experience working with communities and providing 911 services will be incredibly beneficial to our residents,” said Kay Sass, Public Affairs and Emergency Management Coordinator for Dover. “In the bidding process, they emerged as the most efficient and cost-effective option available. We’ve already seen incredible collaboration by Ambulnz with the City and community partners so far – in fact, prior to the contract starting, they stepped up to provide necessary standby EMS services at several local events with little notice.”
DocGo strives to deliver mobile health and emergency services to residents and customers and provide high-quality, highly-accessible care for patients when and where they need it most.
About DocGo
DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo’s proprietary technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient’s home or workplace. Together with DocGo’s integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, the plans, strategies, outcomes, and prospects, both business and financial, of the Company, including the Company’s provision of services pursuant to its new contracts and the expected benefits of such contracts. These statements are based on the beliefs and assumptions of the Company’s management. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions, outcomes, results or expectations. Accordingly, you should not place undue reliance on such statements. All statements other than statements of historical fact are forward-looking. In some cases, these statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “might,” “will,” “should,” “could,” “can,” “would,” “design,” “potential,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends” or the negative of these terms or similar expressions.
Forward-looking statements are inherently subject to substantial risks, uncertainties and assumptions, many of which are beyond the Company’s control, and which may cause the Company’s actual results or outcomes, or the timing of results or outcomes, to differ materially from those contained in the Company’s forward-looking statements, including, but not limited to the following: the ability of the Company to realize the benefits of its contracts; the Company’s ability to successfully implement its business strategy; the Company’s reliance on and ability to maintain its contractual relationships with its healthcare provider partners and clients; the Company’s ability to compete effectively in a highly competitive industry; the Company’s ability to maintain existing contracts; the Company’s reliance on government contracts; the Company’s ability to effectively manage its growth; the Company’s financial performance and future prospects; the Company’s ability to deliver on its business strategies or models, plans and goals; the Company’s ability to expand geographically; the Company’s competitive position and opportunities, including its ability to realize the benefits from its operating model; and other risk factors included in the Company’s filings with the Securities and Exchange Commission.
The forward-looking statements made in this press release are based on events or circumstances as of the date on which the statements are made. The Company undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as and to the extent required by law.
Last Trade: | US$3.63 |
Daily Change: | -0.01 -0.27 |
Daily Volume: | 602,138 |
Market Cap: | US$371.420M |
August 07, 2024 August 05, 2024 August 02, 2024 June 24, 2024 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB